Lv51
1380 积分 2023-06-14 加入
obesity week Poster Abstracts
21天前
已完结
obesity week Oral Abstracts
21天前
已完结
Structure of the full-length glucagon class B G-protein-coupled receptor
1个月前
已完结
Target identification and assessment in the era of AI
1个月前
已完结
Strategic Design of Triple GLP-1R/GCGR/GIPR Agonists with Varied Receptor Potency: Achieving Comparable Glycemic and Weight Reduction Effects
1个月前
已完结
Discovery of AMG 133, a Glucose-Dependent Insulinotropic Polypeptide Receptor Antagonist and Glucagon-Like Peptide 1 Receptor Agonist Antibody-Drug Conjugate for the Treatment of Obesity
1个月前
已完结
New Insights into Modes of GPCR Activation
1个月前
已完结
Rational design of Gi-biased CB1 agonist with reduced side effects
1个月前
已完结
Population pharmacokinetic analysis of certolizumab pegol in patients with Crohn's disease
1个月前
已完结
Tolerability of hypertonic injectables
1个月前
已完结
皖公网安备34019202002308
